| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |